September 2009 Volume 5, Issue 9

Volume 5, Issue 9 | September 2009

September 2009

In this Issue

Research & Development

Drug Discovery News Placeholder Image

BMS acquires Medarex for $2.1B

Merger is part of 'string of pearls' growth strategy; larger deals may follow
Drug Discovery News Placeholder Image

Personalized cancer therapy

EMD Serono teams up with M.D. Anderson researchers to accelerate development of effective oncology drugs
Drug Discovery News Placeholder Image

Diabetes a sweet spot for collaboration

Juvenile Diabetes Research Foundation and Novartis’ Genomics Institute forge diabetes drug partnership
Drug Discovery News Placeholder Image

Deterioration detection

AstraZeneca, Australia's MHRI collaborate on early detection of Alzheimer's
Drug Discovery News Placeholder Image

From Russia with love

Merck Serono joins Russian-led team at MSM Protein Technologies to raise antibodies to complex cell surface receptors

Automation & Instrumentation

Drug Discovery News Placeholder Image

Agilent, Varian mum on blockbuster deal

Proposed $1.5 billion merger would solidify Agilent's position in bio-analytical measurement
Drug Discovery News Placeholder Image

Google that virus

Roche lends Google.org technological muscle for efforts centered on better tracking of viruses and preventing their spread
Drug Discovery News Placeholder Image

Stretching out a bit

Millipore expands drug discovery and development services in Europe with BioAnaLab acquisition
Drug Discovery News Placeholder Image

Firstest with the mostest

Bruker Daltonics’ mass spec joint venture in India aims at market leadership
Drug Discovery News Placeholder Image

Bringing separations together

After several acquisitions and a closed-door transformation, Grace Davison emerges as full-fledged separations business with Reveleris system

Genomics & Proteomics

Drug Discovery News Placeholder Image

Unmasking the villain

University of North Carolina researchers decode the structure of an entire HIV genome
Drug Discovery News Placeholder Image

Covance picks up Merck lab

Company acquires Seattle-based Gene Expression Laboratory and will provide Merck with genomic analysis services
Drug Discovery News Placeholder Image

Genomics on the mind

Lilly and SeqWright team up with a pair of Roche business units to get to genetic roots of psychiatric diseases
Drug Discovery News Placeholder Image

Aptamers as a targeting moiety in two deals

Archemix aptamers to carry the payload for miRagen and Dicerna RNA therapeutics
Drug Discovery News Placeholder Image

Alnylam, Tekmira target RNAi therapeutics

In a move aimed at the discovery of novel cationic lipids and lipid nanoparticles for the systemic delivery of RNAi therapeutics, Alnylam Pharmaceuticals Inc. and Tekmira Pharmaceuticals Corp. have joined forces and launched a new company, AlCana Technologies Inc.

Informatics

Drug Discovery News Placeholder Image

Silo breakdown

Sigma-Aldrich acquires ChemNavigator to give researchers a one-stop shop for compound selection and procurement services
Drug Discovery News Placeholder Image

Data analysis double play

Maaguzi and Covance acquisitions solidify Phase Forward’s leadership aims in the integrated clinical research suite market
Drug Discovery News Placeholder Image

Picture perfect

FujiFilm Imaging Colorants selects Dotmatics to provide research data visualization solutions
Drug Discovery News Placeholder Image

EDC made easy

Korea’s DreamCIS selects Oracle Health Sciences software solutions to speed clinical trial data collection
Drug Discovery News Placeholder Image

First comes love, then comes marriage

After one-year partnership on Phase I trial electronic data capture solutions, OmniComm acquires EDC assets of Logos Technologies

Commentary

Drug Discovery News Placeholder Image

Sample management: The elephant in the room?

Upgrading sample management and storage can represent a significant initial investment, but the benefits far exceed the costs. By upgrading sample management systems, the “elephant in the room” can be exposed and removed, saving time and money and averting a wide range of problems.
Drug Discovery News Placeholder Image

Why study a drug in distilled water when urine is cheaper?

Or is it? This is the title I used at an American Chemical Society symposium on clinical chemistry in the late 1970s. Even in my youth, I was complaining about analytical chemistry faculty doing things that had very little biological relevance, when it was not that hard to do the opposite. Thirty years later, I’ve had to modify my opinion because urine, blood, rats, tissue, saliva and all the rest have recently become very expensive, and properly so.

Editor's Focus

Drug Discovery News Placeholder Image

‘Miles to go’ before Kennedy’s vision of healthcare reform is realized

On Aug. 25, Massachusetts Sen. Edward “Ted” Kennedy passed away at the age of 77 after battling a malignant glioma, leaving our nation to celebrate his accomplishments and wonder how his passing will affect Congress’ current healthcare reform proposals.

Global News

Drug Discovery News Placeholder Image

Sanofi’s booster shot

Sanofi Pasteur strengthens vaccines position in India through control of Shantha Biotechnics
Drug Discovery News Placeholder Image

Novartis sponsors Avila Therapeutics’ covalent drug candidate

Avila Therapeutics Inc. has entered into an option agreement with the Novartis Option Fund focused on Avila’s advancement of a novel covalent drug program from Avila’s research pipeline in conjunction with an equity investment
Drug Discovery News Placeholder Image

Transoceanic translational collaboration

Applied Bio's sequencing technology to be used by Australian university to accelerate pancreatic and ovarian cancer research
Drug Discovery News Placeholder Image

Research across the Pacific

AlphaRx and Venturepharm announce agreement to develop drug development center in China
Drug Discovery News Placeholder Image

BioFocus DPI, Oncodesign join forces in oncology discovery

BioFocus DPI and Oncodesign have pooled their expertise and resources to form a drug discovery service specializing in the rapid generation of promising anticancer drugs

New Products

Drug Discovery News Placeholder Image

Biotin-binding microplates with higher sensitivity

Thermo Fisher Scientific has expanded its line of biotin-binding microplates with the introduction of the Thermo Scientific Pierce High Sensitivity Streptavidin and NeutrAvidin Coated Plates.
Drug Discovery News Placeholder Image

Improved efficiency of intracellular delivery of bioactive molecules

Biocompatibles has launched a new product in its CelLuminate range of intracellular delivery systems.
Drug Discovery News Placeholder Image

New epoch in spectrophotometer technology

BioTek has launched the Epoch Multi-Volume Spectrophotometer System for monochromator based absorbance measurements in volumes as low as 2 µL.
Drug Discovery News Placeholder Image

New mouse stem and primary cells

The Jackson Laboratory has introduced two new research tools—JAX Mouse Embryonic Stem Cells (mES) and JAX Mouse Embryonic Fibroblasts (MEFs). JAX mES cells are self-renewing, non-transformed cell lines established from day 3.5 blastocysts and can differentiate into all three embryonic germ layers: endoderm, ectoderm and mesoderm.

Bench Press

Drug Discovery News Placeholder Image

Natural-born killers identified by British researchers

A team of British researchers, led by Dr. Hugh Brady of Imperial College London’s Department of Life Sciences and publishing in the journal Nature Immunology in mid-September, have identified the master gene that causes blood stem cells to turn into disease-fighting natural killer immune cells. This is a discovery that the team, which included researchers from University College London and the Medical Research Council’s National Institute for Medical Research, believes could one day help scientists boost the body’s production of these frontline tumor-killing cells, creating new ways to treat cancer.

Feature

Drug Discovery News Placeholder Image

What’s on your mind?

The Windy City will host the 39th annual meeting of the Society for Neuroscience
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue